Politician trade (House)

Johnson & Johnson (JNJ)Rep. Marjorie Taylor Mrs Greene (GA14) disclosed a purchase $1K–$15K

Rep. Marjorie Taylor Mrs Greene (GA14) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
3 days
Disclosure lag
Traded
Dec 24, 2024
Disclosed
Dec 27, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  2. Nov 8, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Nov 22, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Nov 25, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Nov 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  6. Dec 6, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Dec 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  8. Dec 12, 2024InsiderDirector purchased ~$147K of JNJ shares in the open market
  9. Dec 12, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  10. Dec 24, 2024 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Dec 31, 2024CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  2. Jan 8, 2025Congress · 1 personMembers of Congress: 4 purchases
  3. Jan 16, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Jan 21, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Jan 23, 2025FDAFDA drug approval: Darzalex
  6. Jan 24, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
  7. Feb 5, 2025FDAFDA device clearance: GRYPHON™ X Anchor; HEALIX TRANSTEND™ Anchor
  8. Feb 7, 2025InsiderCFO sold ~$2M of JNJ shares in the open market
  9. Feb 18, 2025InsiderChair sold ~$63K of JNJ shares in the open market
  10. Feb 24, 2025FDARecall: COR Disposable Kit, 8 mm. Cartilage Transplant System.
  11. Feb 24, 2025FDARecall: COR Disposable Kit, 8 mm w/ Perpendicularity. Cartilage Transplant System.
  12. Feb 24, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  13. Feb 25, 2025FDAFDA device clearance: ECHELON LINEAR™ Stapler 30mm Stapler (GTX30); ECHELON LINEAR™ Stapler 60mm Stapler (GTX60); ECHELON LINEAR™ Stapler 90mm Stapler (GTX90); ECHELON LINEAR™ Stapl…
  14. Feb 25, 2025InsiderOfficer sold ~$1.16M of JNJ shares in the open market
  15. Feb 28, 2025FDAFDA drug approval: Opsumit
  16. Mar 3, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  17. Mar 4, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  18. Mar 5, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  19. Mar 7, 2025FDARecall: PDS¿PLUS¿VIO¿30IN(75CM)¿USP6-0(M0.7)¿D/A¿C-1¿MP
  20. Mar 7, 2025FDARecall: PROLENE BLU 18IN(45CM) USP6-0(M0.7) S/A P-1 PRM
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Marjorie Taylor Mrs Greene (GA14)

The full history of Rep. Marjorie Taylor Mrs Greene (GA14) is on the profile page.

How this filing works

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data